Latest News and Press Releases

AtaiBeckley announced participation in the 64th Annual Meeting of the American College of Neuropsychopharmacology (ACNP)

RICHMOND, Ind., Jan. 15, 2026 (GLOBE NEWSWIRE) -- Liberation Bioindustries announces its co-founders have assumed new roles in the company; originally Chief Executive Officer (CEO), Mark Warner is...

Dublin, Jan. 15, 2026 (GLOBE NEWSWIRE) -- The "Rare Cell Isolation Market Forecast to 2033" report has been added to ResearchAndMarkets.com's offering.The global rare cell isolation market size was...

Dublin, Jan. 15, 2026 (GLOBE NEWSWIRE) -- The "Fetal Bovine Serum Market Size, Share & Trends Analysis Report by Application (Drug Discovery, Vaccine Production, Cell-based Research,...

Phase 2 (~50% of patients evaluated to date at 12 months) shows 46% lesion growth reduction vs. controlThere are no OCU410-related serious adverse events reported across the Phase 1 and Phase 2...

Stablepharma and AFT Pharmaceuticals (NZX: AFT; ASX: AFP) partner to address multi-billion dollar anti-infective and oncology therapeutics market

BCC Research highlights high-growth opportunities across advanced technologies reshaping manufacturing, biotechnology, energy systems, and digital infra.

Dublin, Jan. 14, 2026 (GLOBE NEWSWIRE) -- The "Best Practices for Supplier Qualification in Life Science Training Course (May 6th - May 7th, 2026)" has been added to ResearchAndMarkets.com's...

SOUTH SAN FRANCISCO, Calif., Jan. 13, 2026 (GLOBE NEWSWIRE) -- BridgeBio Oncology Therapeutics, Inc., or BBOT (NASDAQ: BBOT), a clinical-stage biopharmaceutical company focused on RAS-pathway...

MALVERN, Pa., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced...